Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 52,548 shares at $2.55 ($128K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Scheduled sale ($128k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 14,100 | $36K | 28.0% |
| 2 | $2.48 | 7,429 | $18K | 14.4% |
| 3 | $2.38 | 31,019 | $74K | 57.6% |
| Total | $2.44 avg | 52,548 | $128K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |